✦ LIBER ✦

523 Tolerability of paglitaxel (Taxol®) in platinum pretreated advanced ovarian cancer patients

✍ Scribed by A. Martoni; C. Zamagni; N. Cacciari; F. Pannuti

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Taxol as Second-Line Treatment in Patien

✍ K. Mayerhofer; E. Kucera; H. Zeisler; P. Speiser; A. Reinthaller; P. Sevelda 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 71 KB

PHARMACOLOGIC STUDY OF 3-HOUR 135 mg m−2

✍ VINODH R.NANNAN PANDAY; MANON T. HUIZING; LAURENCE J.C. van WARMERDAM; RIA C. DU 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Weekly combination of taxol, 5-fluoroura

✍ Nisticò, C.; D'Ottavio, A.M.; Frontini, L.; Vaccaro, A.; Garufi, C.; Barni, S.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 156 KB

The Costs and Efficacy of Liposomal Doxo

✍ Martee L. Hensley; Brad Hoppe; Larry Leon; Paul Sabbatini; Carol Aghajanian; Den 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Efficacy and tolerability of gefitinib i

✍ Cappuzzo, F; Bartolini, S; Ceresoli, G L; Tamberi, S; Spreafico, A; Lombardo, L; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

Phase I/II study of oral etoposide plus

✍ Baur, M; Schernhammer, E; Gneist, M; Sevelda, P; Speiser, P; Hudec, M; Dittrich, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 109 KB